Yatharth Hospital & Trauma Care Services Ltd

Yatharth Hospital & Trauma Care Services Ltd maintains a strong liquidity position, with a current ratio of 7.59, indicating a significant buffer of current assets over current liabilities. The company's liquidity_fpt score is high, supported by cash and equivalents of INR 1,126.96 million, which is a substantial portion of its total assets. This liquidity position is further reinforced by a low debt-to-equity ratio of 0.1, suggesting minimal reliance on debt financing. In terms of profitability, the company's return on equity (ROE) of 4.39% and return on assets (ROA) of 3.76% are below the industry median for healthcare facilities and services, indicating that the company is not generating returns as efficiently as its peers. The net income of INR 383.48 million on a revenue of INR 1,779.67 million suggests a net margin of approximately 21.5%, which is relatively strong but not exceptional within the industry. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification may expose the company to regional economic or regulatory risks, although the current risk assessment does not flag this as a high concern. Looking ahead, the company is projected to experience moderate growth, with revenue expected to increase in the current fiscal year and the following year. The operating cash flow of INR -30.78 million and capital expenditure of INR -933.65 million indicate that the company is investing in its operations, which could support future growth. However, the negative operating cash flow suggests that the company is currently spending more than it is generating from operations, which may require continued reliance on financing or asset sales. The risk assessment indicates a low probability of dilution and no immediate liquidity concerns. The company's capital structure is stable, with a low debt-to-equity ratio and a strong equity base of INR 8,743.23 million. The absence of dilution flags and the low dilution risk suggest that the company is not expected to issue additional shares in the near term, preserving shareholder value. Recent filings and transcripts do not indicate any material events that would significantly impact the company's operations or financial position. The company's management has not disclosed any major strategic shifts or regulatory challenges in the latest reports. Analysts have assigned a mean recommendation of 2.00, indicating a "buy" rating, with a mean price target of INR 910.00, suggesting a positive outlook from the investment community.